We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bellerophon Therapeutics Inc | NASDAQ:BLPH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.1025 | 0.112 | 0.1139 | 0 | 01:00:00 |
Bellerophon Therapeutics, Inc
.
|
Delaware
|
001-36845
|
47-3116175
|
(State or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
184 Liberty Corner Road, Suite 302
Warren, New Jersey
|
07059
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
(Former Name or Former Address, if Changed Since Last Report)
|
|
x
|
Emerging growth company
|
|
x
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
BELLEROPHON THERAPEUTICS, INC.
|
||
|
|
|
|
|||
Date: September 14, 2017
|
|
|
|
By:
|
|
/s/ Megan Schoeps
|
|
|
|
|
|
|
Megan Schoeps
Controller and Principal Financial Officer
|
1 Year Bellerophon Therapeutics Chart |
1 Month Bellerophon Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions